Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Change of Adviser

November 6, 2020
RNS Number : 4449E Renalytix AI PLC 06 November 2020       Renalytix AI plc (" RenalytixAI " or the " Company ")   Change of adviser   NEW YORK , November 6, 2020    - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on

Posting of Annual Report & Accounts &Notice of AGM

November 2, 2020
RNS Number : 9886D Renalytix AI PLC 02 November 2020       Renalytix AI plc (" RenalytixAI " or the " Company ")   Posting of Annual Report & Accounts and Notice of AGM   NEW YORK , November 2, 2020    - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro

Full Year Report

October 27, 2020
RNS Number : 3088D Renalytix AI PLC 27 October 2020     Renalytix AI plc (" RenalytixAI " or the " Company ")   Full Year Report   NEW YORK , October 27, 2020   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing

Notice of Results

October 16, 2020
RNS Number : 2682C Renalytix AI PLC 16 October 2020       Renalytix AI plc (" RenalytixAI " or the " Company ")   Notice of results Analyst and Investor presentations   RenalytixAI To Announce Financial Results for Full Year Ended June 30, 2020 and Provide Corporate Update   NEW YORK , October 16,

Verici Dx - Intention to admit to trading on AIM

October 13, 2020
RNS Number : 9631B Renalytix AI PLC 13 October 2020   Not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or within the United States , Australia , Canada , Hong Kong , Japan , New Zealand , the Republic of South Africa or any other jurisdiction where

California Commercial Lab Certification Recieved

September 22, 2020
RNS Number : 6495Z Renalytix AI PLC 22 September 2020   This announcement contains inside information   Renalytix AI plc ("RenalytixAI", the "Company")   RenalytixAI Receives California Commercial Laboratory Certification   RenalytixAI is now currently licensed to provide KidneyIntelX testing

KidneyIntelX clinical testing launch

September 18, 2020
RNS Number : 4123Z Renalytix AI PLC 18 September 2020     This announcement contains inside information   Renalytix AI plc ("RenalytixAI", the "Company")   RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System   NEW YORK , September 18, 2020 - Renalytix AI

Grant of Purchase Rights and Verici update

September 2, 2020
RNS Number : 7366X Renalytix AI PLC 02 September 2020     Renalytix AI plc ("RenalytixAI", the "Company")   Grant of Purchase Rights under the 2020 Employee Share Purchase Plan and Verici update   NEW YORK , September 2, 2020 - Renalytix AI plc ( LSE: RENX) (NASDAQ: RNLX) announces that on 28

Submission seeking FDA Clearance of KidneyIntelX

August 26, 2020
RNS Number : 1457X Renalytix AI PLC 26 August 2020   Renalytix AI plc ("RenalytixAI", the "Company")   RenalytixAI Files Submission Seeking U.S. FDA Clearance of KidneyIntelX     NEW YORK , August 26, 2020 - Renalytix AI plc ( LSE: RENX) (NASDAQ: RNLX), an artificial intelligence -enabled in vitro

RenalytixAI to Collaborate with AstraZeneca

August 21, 2020
RNS Number : 7551W Renalytix AI PLC 21 August 2020     Renalytix AI plc ("RenalytixAI", the "Company")   RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease   Parties to adopt multi-phase approach to develop precision medicine strategies to optimize
Displaying 191 - 200 of 286